Padilla, Baby Girl .

HRN: 21-57-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/01/2022
07/13/2022
IV
4mg
Q48h
Live Preterm Female Neonate Del Via NSVD, AS 3,5,7, BS 28-29weeks, RDS Of Prematurity, Sepsis Neonatorum
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: